Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (50) 50
life sciences & biomedicine (49) 49
humans (41) 41
oncology (37) 37
female (25) 25
middle aged (23) 23
aged (20) 20
clinical trials (19) 19
male (18) 18
biological and medical sciences (15) 15
medical sciences (15) 15
adult (14) 14
breast cancer (14) 14
care and treatment (14) 14
disease-free survival (14) 14
tumors (13) 13
abridged index medicus (12) 12
breast neoplasms - drug therapy (12) 12
treatment outcome (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
cancer (10) 10
general & internal medicine (10) 10
medicine, general & internal (9) 9
survival analysis (9) 9
chemotherapy (8) 8
research (8) 8
aged, 80 and over (7) 7
analysis (7) 7
antineoplastic agents (7) 7
metastases (7) 7
metastasis (7) 7
patient outcomes (7) 7
radiotherapy (7) 7
survival (7) 7
antineoplastic agents - therapeutic use (6) 6
cancer therapies (6) 6
drug therapy (6) 6
health aspects (6) 6
medical research (6) 6
prostate cancer (6) 6
quality of life (6) 6
survival rate (6) 6
antineoplastic agents - administration & dosage (5) 5
antineoplastic agents, hormonal - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
breast neoplasms - pathology (5) 5
chemotherapy, adjuvant (5) 5
combined modality therapy (5) 5
deoxycytidine - administration & dosage (5) 5
deoxycytidine - analogs & derivatives (5) 5
double-blind method (5) 5
follow-up studies (5) 5
patients (5) 5
prognosis (5) 5
prostatic neoplasms - therapy (5) 5
quinazolines - administration & dosage (5) 5
research design (5) 5
risk factors (5) 5
androgen antagonists - therapeutic use (4) 4
antimitotic agents (4) 4
gynecology. andrology. obstetrics (4) 4
kaplan-meier estimate (4) 4
metformin (4) 4
neoplasm metastasis (4) 4
original reports (4) 4
pancreatic neoplasms - drug therapy (4) 4
placebos (4) 4
prostatic neoplasms - mortality (4) 4
radiation (4) 4
radiation therapy (4) 4
randomized controlled trials as topic (4) 4
retrospective studies (4) 4
statistics as topic (4) 4
time factors (4) 4
usage (4) 4
adjuvant treatment (3) 3
biomarkers (3) 3
body mass index (3) 3
bone neoplasms - secondary (3) 3
breast neoplasms - blood (3) 3
breast neoplasms - mortality (3) 3
canada (3) 3
checklist (3) 3
chemoradiotherapy (3) 3
clinical trials, phase iii as topic (3) 3
disease progression (3) 3
drug administration schedule (3) 3
endocrine therapy (3) 3
erbb-2 protein (3) 3
erlotinib (3) 3
erlotinib hydrochloride (3) 3
fluorouracil - administration & dosage (3) 3
gemcitabine (3) 3
hematology, oncology and palliative medicine (3) 3
medicine & public health (3) 3
mortality (3) 3
multicenter studies as topic (3) 3
multivariate analysis (3) 3
neoplasm staging (3) 3
nephrology. urinary tract diseases (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
by Davis, Ian D and Martin, Andrew J and Stockler, Martin R and Begbie, Stephen and Chi, Kim N and Chowdhury, Simon and Coskinas, Xanthi and Frydenberg, Mark and Hague, Wendy E and Horvath, Lisa G and Joshua, Anthony M and Lawrence, Nicola J and Marx, Gavin and McCaffrey, John and McDermott, Ray and McJannett, Margaret and North, Scott A and Parnis, Francis and Parulekar, Wendy and Pook, David W and Reaume, M. Neil and Sandhu, Shahneen K and Tan, Alvin and Tan, T. Hsiang and Thomson, Alastair and Tu, Emily and Vera-Badillo, Francisco and Williams, Scott G and Yip, Sonia and Zhang, Alison Y and Zielinski, Robert R and Sweeney, Christopher J and Australian New Zealand Urogenital and ENZAMET Trial Investigators and ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group
The New England journal of medicine, ISSN 0028-4793, 07/2019, Volume 381, Issue 2, pp. 121 - 131
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Phenylthiohydantoin - adverse effects | Androgen Receptor Antagonists - therapeutic use | Digestive System Neoplasms - secondary | Follow-Up Studies | Phenylthiohydantoin - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Bone Neoplasms - secondary | Male | Fatigue - chemically induced | Androgen Receptor Antagonists - adverse effects | Seizures - chemically induced | Digestive System Neoplasms - drug therapy | Bone Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Kaplan-Meier Estimate | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Phenylthiohydantoin - analogs & derivatives | Prostatic Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Progression-Free Survival | Aged | Adenocarcinoma - mortality | Medical research | Medical imaging | Prostate-specific antigen | Clinical trials | Metastasis | Cancer therapies | Survival | Patients | Metastases | Design | Testosterone | Androgens | Castration | Prostate cancer | Seizures
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Regional Nodal Irradiation in Early-Stage Breast Cancer
by Whelan, Timothy J and Olivotto, Ivo A and Parulekar, Wendy R and Ackerman, Ida and Chua, Boon H and Nabid, Abdenour and Vallis, Katherine A and White, Julia R and Rousseau, Pierre and Fortin, Andre and Pierce, Lori J and Manchul, Lee and Chafe, Susan and Nolan, Maureen C and Craighead, Peter and Bowen, Julie and McCready, David R and Pritchard, Kathleen I and Gelmon, Karen and Murray, Yvonne and Chapman, Judy-Anne W and Chen, Bingshu E and Levine, Mark N and MA 20 Study Investigators and MA.20 Study Investigators
The New England journal of medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 4, pp. 307 - 316
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lymphatic Metastasis - radiotherapy | Follow-Up Studies | Neoplasm Recurrence, Local - prevention & control | Humans | Middle Aged | Risk | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Radiotherapy - adverse effects | Radiation Dosage | Breast Neoplasms - therapy | Breast Neoplasms - radiotherapy | Mastectomy, Segmental | Survival Analysis | Aged, 80 and over | Adult | Breast Neoplasms - mortality | Female | Aged | Sentinel Lymph Node Biopsy | Neoplasm Staging | Clinical trials | Care and treatment | Usage | Breast cancer | Diagnosis | Lymphatic system | Pneumonitis | Lymphedema | Clavicle | Biopsy | Surgery | Radiation | Radiation therapy | Survival | Lymph nodes | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
by Warde, Padraig, Dr and Mason, Malcolm, MB and Ding, Keyue, PhD and Kirkbride, Peter, MB and Brundage, Michael, MD and Cowan, Richard, MB and Gospodarowicz, Mary, MD and Sanders, Karen, BSc and Kostashuk, Edmund, MD and Swanson, Greg, MD and Barber, Jim, MB and Hiltz, Andrea, MSc and Parmar, Mahesh KB, PhD and Sathya, Jinka, MB and Anderson, John, MB and Hayter, Charles, MD and Hetherington, John, MB and Sydes, Matthew R, CStat and Parulekar, Wendy, MD and for the NCIC CTG PR.3/MRC UK PR07 investigators and NCICCTG PR3 MRC UK PR07 Investigat and NCIC CTG PR.3/MRC UK PR07 investigators
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9809, pp. 2104 - 2111
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Prostatic Neoplasms - radiotherapy | Humans | Male | Survival Rate | Combined Modality Therapy | Radiotherapy - adverse effects | Prostatic Neoplasms - mortality | Orchiectomy | Prostatic Neoplasms - therapy | Adenocarcinoma - therapy | Aged, 80 and over | Androgen Antagonists - therapeutic use | Quality of Life | Androgen Antagonists - adverse effects | Gonadotropin-Releasing Hormone - agonists | Adenocarcinoma - mortality | Adenocarcinoma - radiotherapy | Androgens | Care and treatment | Usage | Patient outcomes | Radiotherapy | Health aspects | Prostate cancer | Clinical trials | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
by Goss, Paul E and Ingle, James N and Pritchard, Kathleen I and Robert, Nicholas J and Muss, Hyman and Gralow, Julie and Gelmon, Karen and Whelan, Tim and Whelan, Kate and Strasser-Weippl, Kathrin and Rubin, Sheldon and Sturtz, Keren and Wolff, Antonio C and Winer, Eric and Hudis, Clifford and Stopeck, Alison and Beck, J. Thaddeus and Kaur, Judith S and Tu, Dongsheng and Parulekar, Wendy R
The New England journal of medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 3, pp. 209 - 219
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Aromatase Inhibitors - administration & dosage | Recurrence | Triazoles - administration & dosage | Triazoles - adverse effects | Double-Blind Method | Drug Administration Schedule | Follow-Up Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Secondary Prevention | Breast Neoplasms - drug therapy | Breast Neoplasms - prevention & control | Incidence | Nitriles - administration & dosage | Disease-Free Survival | Aromatase Inhibitors - adverse effects | Postmenopause | Quality of Life | Female | Aged | Chemotherapy, Adjuvant | Nitriles - adverse effects | Breast Neoplasms - epidemiology | Care and treatment | Breast cancer | Middle aged women | Drug therapy | Health aspects | Inhibitor drugs | Estrogens | Endocrine therapy | Preventive medicine | Tamoxifen | Cancer therapies | Survival | Post-menopause | Quality of life | Osteoporosis | Chemotherapy | Fractures | Pain | Womens health | Aromatase | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text SPIRIT 2013 statement: Defining standard protocol items for clinical trials
by Chan, An-Wen and Tetzlaff, Jennifer M and Altman, Douglas G and Laupacis, Andreas and Gøtzsche, Peter C and Krleža-Jerić, Karmela and Hróbjartsson, Asbjørn and Mann, Howard and Dickersin, Kay and Berlin, Jesse A and Doré, Caroline J and Parulekar, Wendy R and Summerskill, William S.M and Groves, Trish and Schulz, Kenneth F and Sox, Harold C and Rockhold, Frank W and Rennie, Drummond and Moher, David
Annals of internal medicine, ISSN 0003-4819, 02/2013, Volume 158, Issue 3, pp. 200 - 207
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Checklist | Clinical Protocols - standards | Clinical Trials as Topic - methods | Clinical Trials as Topic - standards | Humans | Clinical trials | Standards | Information management | Protocol | Research methodology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Metastasis-free survival is a strong Surrogate of overall survival in localized prostate cancer
by Xie, Wanling and Regan, Meredith M and Buyse, Marc and Halabi, Susan and Kantoff, Philip W and Sartor, Oliver and Soule, Howard and Clarke, Noel W and Collette, Laurence and Dignam, James J and Fizazi, Karim and Paruleker, Wendy R and Sandler, Howard M and Sydes, Matthew R and Tombal, Bertrand and Williams, Scott G and Sweeney, Christopher J and Andren, Ove and Armstrong, John and Berry, Donald and Bolla, Michel and Chin, Joseph and Chowdhury, Simon and Clarke, Noel and Cooperberg, Matthew and Denham, Jim and Dignam, James and Di Stasi, Savino Mauro and Eisenberger, Mario and Freidlin, Boris and Gillessen, Silke and Gleave, Martin and Habibian, Muriel and James, Nicholas and Jarow, Jonathan and Keating, Nancy and Keloff, Gary and Klotz, Laurence and Lukka, Himu and Mason, Malcolm and Miyahira, Andrea and Mottet, Nicolas and Nakabayashi, Mari and Parulekar, Wendy R and Regan, Meredith and Sandler, Howard and Scardino, Peter and Scher, Howard and Simon, Richard and Simons, Jonathan and Small, Eric and Sydes, Matthew and Tangen, Catherine and Thompson, Ian and Widmark, Anders and Wiegel, Thomas and Wirth, Manfred and Yeoh, Eric and Zapatero, Almudena and ICECaP Working Grp and ICECaP Working Group and on behalf of the ICECaP Working Group
Journal of clinical oncology, ISSN 0732-183X, 09/2017, Volume 35, Issue 27, pp. 3097 - 3104
Life Sciences & Biomedicine | Oncology | Science & Technology | Disease-Free Survival | Prostatic Neoplasms - pathology | Neoplasm Metastasis | Humans | Risk Factors | Endpoint Determination | Survival Analysis | Male | Combined Modality Therapy | Prostatic Neoplasms - therapy | Randomized Controlled Trials as Topic | Index Medicus | ORIGINAL REPORTS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
by Chan, An-Wen and Tetzlaff, Jennifer M and Gøtzsche, Peter C and Altman, Douglas G and Mann, Howard and Berlin, Jesse A and Dickersin, Kay and Hróbjartsson, Asbjørn and Schulz, Kenneth F and Parulekar, Wendy R and Krleža-Jerić, Karmela and Laupacis, Andreas and Moher, David
BMJ : British Medical Journal, ISSN 1756-1833, 1/2013, Volume 346, Issue jan08 15, pp. e7586 - e7586
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Ethics, Medical | Clinical Trials as Topic - statistics & numerical data | Humans | Medical Audit | Clinical Protocols - standards | Treatment Outcome | Professional Role | Statistics as Topic | Random Allocation | Data Collection - methods | Patient Selection | Research Support as Topic | Sample Size | Social Responsibility | Clinical Trials Data Monitoring Committees | Research Personnel | Time Factors | Computer Security | Checklist | Clinical Trials as Topic - methods | Clinical Trials as Topic - standards | Research Design | Practice Guidelines as Topic | Quality Control | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights